Status:
RECRUITING
Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Obesity
Type 2 Diabetes Mellitus
Eligibility:
All Genders
16-70 years
Brief Summary
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
Detailed Description
In this study, the investigator intend to collect abdominal CT from patients who are proposed to undergo bariatric surgery, to extract the radiomics of intra-abdominal fat and subcutaneous fat, and to...
Eligibility Criteria
Inclusion
- BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery
Exclusion
- Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06169033
Start Date
January 1 2024
End Date
December 31 2027
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yuntao Nie
Beijing, China, 100029